NO20026212L - Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen - Google Patents
Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsenInfo
- Publication number
- NO20026212L NO20026212L NO20026212A NO20026212A NO20026212L NO 20026212 L NO20026212 L NO 20026212L NO 20026212 A NO20026212 A NO 20026212A NO 20026212 A NO20026212 A NO 20026212A NO 20026212 L NO20026212 L NO 20026212L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- preparation
- delivery system
- drug delivery
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000195919 | 2000-06-29 | ||
| PCT/JP2001/005498 WO2002000734A1 (fr) | 2000-06-29 | 2001-06-27 | Compose dds et son procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20026212D0 NO20026212D0 (no) | 2002-12-23 |
| NO20026212L true NO20026212L (no) | 2003-02-06 |
Family
ID=18694503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20026212A NO20026212L (no) | 2000-06-29 | 2002-12-23 | Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030166513A1 (zh) |
| EP (1) | EP1298145A4 (zh) |
| KR (1) | KR20030031502A (zh) |
| CN (1) | CN1449412A (zh) |
| AU (1) | AU2001267831A1 (zh) |
| BR (1) | BR0112287A (zh) |
| CA (1) | CA2412582A1 (zh) |
| IL (1) | IL153505A0 (zh) |
| MX (1) | MXPA02012791A (zh) |
| NO (1) | NO20026212L (zh) |
| WO (1) | WO2002000734A1 (zh) |
| ZA (1) | ZA200300743B (zh) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996003651A1 (de) | 1994-07-25 | 1996-02-08 | Boehringer Mannheim Gmbh | Metallchelat-markierte peptide |
| PL221351B1 (pl) | 2012-03-14 | 2016-03-31 | Politechnika Warszawska | Sposób otrzymywania nanocząstek polisacharydowych |
| KR102052319B1 (ko) * | 2012-10-11 | 2019-12-05 | 다이이찌 산쿄 가부시키가이샤 | 항체-약물 콘주게이트 |
| EP2910573B1 (en) * | 2012-10-19 | 2020-02-19 | Daiichi Sankyo Company, Limited | Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| SI3088419T1 (sl) | 2013-12-25 | 2019-01-31 | Daiichi Sankyo Company | Zdravilni konjugat anti trop2 protitelesa |
| CN110464847B (zh) | 2014-01-31 | 2024-02-09 | 第一三共株式会社 | 抗her2抗体－药物偶联物 |
| JP2017114763A (ja) * | 2014-03-26 | 2017-06-29 | 第一三共株式会社 | 抗ｃｄ９８抗体−薬物コンジュゲート |
| EP3789042B1 (en) | 2014-04-10 | 2024-11-06 | Daiichi Sankyo Company, Limited | Method for producing anti-her3 antibody-drug conjugate |
| US11185594B2 (en) | 2014-04-10 | 2021-11-30 | Daiichi Sankyo Company, Limited | (Anti-HER2 antibody)-drug conjugate |
| CN107922477B (zh) | 2015-06-29 | 2022-11-01 | 第一三共株式会社 | 用于选择性制造抗体-药物缀合物的方法 |
| FR3045608A1 (fr) * | 2015-12-18 | 2017-06-23 | Rhodia Operations | Dextrane carboxyle |
| WO2018110515A1 (ja) | 2016-12-12 | 2018-06-21 | 第一三共株式会社 | 抗体－薬物コンジュゲートと免疫チェックポイント阻害剤の組み合わせ |
| AU2018210081A1 (en) | 2017-01-17 | 2019-08-08 | Daiichi Sankyo Company, Limited | Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugate |
| TWI855528B (zh) | 2017-05-15 | 2024-09-11 | 日商第一三共股份有限公司 | 抗體-藥物結合物之製造方法 |
| AU2018327170B2 (en) | 2017-08-31 | 2021-03-11 | Daiichi Sankyo Company, Limited | Novel method for producing antibody-drug conjugate |
| CN111051330A (zh) | 2017-08-31 | 2020-04-21 | 第一三共株式会社 | 抗体-药物缀合物的改进制备方法 |
| HRP20230787T1 (hr) | 2018-05-18 | 2023-10-27 | Glycotope Gmbh | Anti-muc1 antitijelo |
| US12220604B2 (en) | 2018-07-31 | 2025-02-11 | Daiichi Sankyo Company, Limited | Treatment of metastatic brain tumor by administration of an antibody-drug conjugate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688931A (en) * | 1993-02-26 | 1997-11-18 | Drug Delivery System Institute, Ltd. | Polysaccharide derivatives and drug carriers |
| SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
| TW409058B (en) * | 1996-06-06 | 2000-10-21 | Daiichi Seiyaku Co | Method for preparation of a drug complex |
| TW527183B (en) * | 1996-06-06 | 2003-04-11 | Daiichi Seiyaku Co | Drug complex |
| CN1250293C (zh) * | 1998-05-22 | 2006-04-12 | 第一制药株式会社 | 药物复合物 |
| IL142842A0 (en) * | 1998-10-30 | 2002-03-10 | Daiichi Seiyaku Co | Dds compounds and method for assaying the same |
| US6815435B2 (en) * | 2000-07-13 | 2004-11-09 | Daiichi Pharmaceutical Co., Ltd. | Pharmaceutical compositions containing DDS compounds |
-
2001
- 2001-06-27 KR KR1020027017768A patent/KR20030031502A/ko not_active Application Discontinuation
- 2001-06-27 AU AU2001267831A patent/AU2001267831A1/en not_active Abandoned
- 2001-06-27 CA CA002412582A patent/CA2412582A1/en not_active Abandoned
- 2001-06-27 CN CN01814617A patent/CN1449412A/zh active Pending
- 2001-06-27 BR BR0112287-8A patent/BR0112287A/pt not_active Application Discontinuation
- 2001-06-27 MX MXPA02012791A patent/MXPA02012791A/es unknown
- 2001-06-27 EP EP01945629A patent/EP1298145A4/en not_active Withdrawn
- 2001-06-27 WO PCT/JP2001/005498 patent/WO2002000734A1/ja not_active Application Discontinuation
- 2001-06-27 US US10/297,584 patent/US20030166513A1/en not_active Abandoned
- 2001-06-27 IL IL15350501A patent/IL153505A0/xx unknown
-
2002
- 2002-12-23 NO NO20026212A patent/NO20026212L/no not_active Application Discontinuation
-
2003
- 2003-01-28 ZA ZA200300743A patent/ZA200300743B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001267831A1 (en) | 2002-01-08 |
| ZA200300743B (en) | 2004-02-10 |
| US20030166513A1 (en) | 2003-09-04 |
| KR20030031502A (ko) | 2003-04-21 |
| CA2412582A1 (en) | 2002-01-03 |
| BR0112287A (pt) | 2003-05-06 |
| WO2002000734A1 (fr) | 2002-01-03 |
| EP1298145A4 (en) | 2004-12-08 |
| EP1298145A1 (en) | 2003-04-02 |
| CN1449412A (zh) | 2003-10-15 |
| NO20026212D0 (no) | 2002-12-23 |
| MXPA02012791A (es) | 2003-12-11 |
| IL153505A0 (en) | 2003-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20016277D0 (no) | Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer | |
| CY2013011I1 (el) | Μεθοδος χορηγησης διφωσφονικων | |
| NO20026212D0 (no) | Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen | |
| DE69935681D1 (de) | Vorrichtungen zur Medikamentverabreichung | |
| DE60019949D1 (de) | Arzneimittel enthaltendes system zur oralen abgabevorrichtung | |
| AU6271401A (en) | Drug administering system and administering method | |
| NO20041315L (no) | Medikamentavleveringssystem | |
| NO20031152D0 (no) | Befruktningshindrende fremgangsmåte og administrasjonsform for det samme | |
| IS6310A (is) | Kínasólínafleiður til lækninga | |
| NO20014035D0 (no) | System for oral administrasjon av medikament | |
| IT1307266B1 (it) | Apparecchio per infusione di farmaci. | |
| DE60016271D1 (de) | Medikamentenzuführvorrichtung | |
| EE04418B1 (et) | Moksifloksatsiini farmatseutiline preparaat | |
| NO20022970D0 (no) | Hydrogel-drevet medikamentdoseringsform | |
| EE200200357A (et) | Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid | |
| NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
| NO20003051D0 (no) | Metode for administrering av AspB28-humant insulin | |
| NO20012047D0 (no) | Medikamentavleveringssystem, spesielt for avlevering av progestiner og östrogener | |
| TR200000534A3 (tr) | Bir ilacin uygulanmasi için metot ve sistem | |
| DE60126089D1 (de) | Verabreichungssystem | |
| NO20015542D0 (no) | Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner | |
| EE200100383A (et) | L-fenüülefriinvesinikkloriidi valmistamise meetod | |
| IS7266A (is) | Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra | |
| DK1178799T3 (da) | Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater | |
| EP1274460A4 (en) | Aqueous PRODRUG COMPOUND WITH A PART OF PACLITAXEL OR ITS DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |